The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

Chief Medical Officer of Northwestern Medicine’s Northwest region of hospitals Dr. Irfan Hafiz joins Bob Sirott to talk about what daily movements can tell you about your longevity, signs of ...

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...

University Hospitals research suggests the Decipher tumor score could help doctors personalize treatment decisions for men ...

The health checks men should stop putting off in their 40s, 50s and 60s - On average, men in the UK die almost four years ...

Erlanger Health has adopted ExactVu, a micro-ultrasound system providing real-time, high-resolution imaging of the prostate. "This advanced technology enhances the ability to identify areas of concern ...

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...

A new DNA test could help doctors determine which men with prostate cancer need more aggressive treatment and which may be spared additional therapy, offering fresh hope of reducing the treatment ...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...

I am 68 years old and have an enlarged prostate and benign prostatic hyperplasia (BPH). I’ve been taking tamsulosin for about seven years. My PSA level has slowly creeped up and was recently measured ...

WTVF News Channel 5 ’s “Morningline” program interviewed Denise Garcia, MD, Assistant Professor of Surgery, about new ...

A number of AI programmes are set to be used by the NHS in England to help doctors spot prostate cancer on MRI scans.